|
|
|
Vol. 15, No. 15, pp. 1946-1956, August 1, 2001
Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA
| |
ABSTRACT |
|---|
|
|
|---|
Previous studies demonstrated that the SAGA (Spt-Ada-Gcn5-Acetyltransferase) complex facilitates the binding of TATA-binding protein (TBP) during transcriptional activation of the GAL1 gene of Saccharomyces cerevisiae. TBP binding was shown to require the SAGA components Spt3 and Spt20/Ada5, but not the SAGA component Gcn5. We have now examined whether SAGA is directly required as a coactivator in vivo by using chromatin immunoprecipitation analysis. Our results demonstrate that SAGA is physically recruited in vivo to the upstream activation sequence (UAS) regions of the galactose-inducible GAL genes. This recruitment is dependent on both induction by galactose and the Gal4 activation domain. Furthermore, we demonstrate that another well-characterized activator, Gal4-VP16, also recruits SAGA in vivo. Finally, we provide evidence that a specific interaction between Spt3 and TBP in vivo is important for Gal4 transcriptional activation at a step after SAGA recruitment. These results, taken together with previous studies, demonstrate a dependent pathway for the recruitment of TBP to GAL gene promoters consisting of the recruitment of SAGA by Gal4 and the subsequent recruitment of TBP by SAGA.
[Key Words: SAGA; Saccharomyces cerevisiae; Gal4; transcription; activation; TBP]
| |
Introduction |
|---|
|
|
|---|
The SAGA
(Spt-Ada-Gcn5-Acetyltransferase)
complex of S. cerevisiae is a large
multiprotein complex that is required for the normal
transcription of many genes (Grant et al. 1998b
; Lee et al. 2000
) and
that is conserved between yeast and humans (for review, see Roth et al.
2001
). SAGA contains several different classes of transcription
factors, including those for which it was named (a subset of Spt
proteins, Ada proteins, and Gcn5, a histone acetyltransferase [HAT]),
a subset of TATA-binding-protein associated factors (TAFs), and the
protein Tra1 (Roth et al. 2001
).
Several lines of evidence demonstrate that SAGA possesses multiple
activities important for transcription. First, genetic analysis of the
nonessential SAGA components has shown that they fall into three
classes by mutant phenotypes: (1) Spt7, Spt20, and Ada1; (2) Spt3 and
Spt8; and (3) Gcn5, Ada2, and Ada3. Mutations in the genes encoding the
first group cause the broadest and most severe set of phenotypes,
whereas mutations in groups 2 and 3 each cause a distinct subset of
these phenotypes (Horiuchi et al. 1997
; Roberts and Winston 1997
;
Sterner et al. 1999
). Second, whole-genome expression analysis of null
mutants representative of these three groups is consistent with this
phenotypic analysis, as an spt20
mutation causes the
greatest effect on expression, whereas spt3
and
gcn5
mutations affect smaller and distinct sets of genes
(Lee et al. 2000
). Finally, biochemical analysis of SAGA mutant
complexes has suggested that the group 1 members, Spt7, Spt20, and
Ada1, are required for SAGA integrity, whereas the other two classes of
SAGA components are not (Grant et al. 1997
; Sterner et al. 1999
).
Furthermore, SAGA complexes purified from gcn5
and
spt3
mutants have distinct biochemical properties (Sterner
et al. 1999
). Taken together, these results suggest that Spt7, Spt20,
and Ada1 are required for all SAGA functions, whereas the two other
groups are each required for a subset of SAGA functions. Recent studies
have indicated that the TAFs within SAGA also play important roles
(Grant et al. 1998a
; Natarajan et al. 1998
).
One SAGA component that has been extensively characterized is the
histone acetyltransferase, Gcn5. Histone acetyltransferases have been
shown to be important in transcriptional activation, and this property
has been demonstrated for Gcn5 both in vivo and in vitro (Roth et al.
2001
). As part of SAGA, Gcn5 acetylates histones H2B and H3 within
nucleosomes (Grant et al. 1997
). Single amino acid changes in the Gcn5
catalytic domain abolish the HAT activity of SAGA in vitro and
transcriptional activation in vivo, demonstrating that the catalytic
activity of Gcn5 is important for transcription at some genes (Kuo et
al. 1998
; Zhang et al. 1998
). Ada2 and Ada3 are also required for
Gcn5's HAT activity on nucleosomal histones, although purified Gcn5 is
still able to acetylate free histone H3 (Candau et al. 1997
).
Another well-characterized SAGA component is the Spt3 protein. Spt3 is
a functionally conserved eukaryotic transcriptional regulator (Madison
and Winston 1998
; Yu et al. 1998
) that is believed to play roles in
both activation and repression of transcription (Winston and Sudarsanam
1998
; Belotserkovskaya et al. 2000
; Lee et al. 2000
). Substantial
genetic and biochemical evidence suggests that Spt3 functions by
interactions with the TATA-binding protein (TBP) (Eisenmann et al.
1992
; Lee and Young 1998
; Dudley et al. 1999
). Interactions between
Spt3 and TBP are also suggested by sequence analysis, as the
amino-terminal and carboxy-terminal regions of Spt3 are homologous to
two human TAFs, hTAFII18 and hTAFII28, respectively
(Mengus et al. 1995
; Birck et al. 1998
). Recent studies have shown that
conserved amino acid changes in TBP that affect genetic interactions
with Spt3 in S. cerevisiae also affect physical and functional
interactions between TBP and hTAFII28 (Lavigne et al. 1999
).
Recent studies of the GAL1 promoter have shown that SAGA is
required for TBP binding, but not for Gal4 binding in vivo (Dudley et
al. 1999
). This SAGA activity was shown to require Spt3 and Spt20, but
it does not significantly require Gcn5. These results suggested a model
in which SAGA is physically recruited to the GAL1 promoter by
interactions with Gal4, followed by physical recruitment of TBP by
interaction with Spt3. We have now tested this model and demonstrate
that SAGA is physically recruited to the GAL1 upstream
activation sequence (UAS) in an activator-dependent fashion.
Furthermore, SAGA is also recruited to other galactose-inducible GAL genes of S. cerevisiae. We also demonstrate that
Gal4-VP16 recruits SAGA in vivo. Finally, we provide new evidence that
Spt3 is required for TBP recruitment, but not for SAGA recruitment, in
vivo. These experiments establish an ordered sequence of events important for transcription initiation in which, upon induction by
galactose, Gal4 recruits SAGA; then SAGA, in an Spt3- and
Spt20-dependent fashion, recruits TBP. Thus, SAGA acts as a coactivator
complex by facilitating rapid transcriptional induction at promoters in vivo. Results in the accompanying manuscript (Bhaumik and Green 2001
)
also provide strong evidence for a crucial role of SAGA as a
coactivator for Gal4 activation.
| |
Results |
|---|
|
|
|---|
Spt3 and Spt20 are recruited to the GAL1-GAL10 UAS on galactose induction
Previous studies showed that both the Spt3 and Spt20 components of
the SAGA complex are required for induction of GAL1
transcription on addition of galactose (Dudley et al. 1999
).
Furthermore, these studies demonstrated that Spt3 and Spt20 are
required for TBP binding to the GAL1 promoter. To test the
hypothesis that Spt3 and Spt20 are directly involved in recruiting TBP
to the GAL1 TATA box, we examined whether Spt3 and Spt20 are
recruited to the GAL1 promoter in vivo by using the method of
chromatin immunoprecipitation (Dedon et al. 1991
; Orlando and Paro
1993
; Strahl-Bolsinger et al. 1997
). In these experiments we detected
Spt3 and Spt20 by using derivatives that contain the haemagglutinin
(HA) epitope tag (see Materials and Methods). These tagged versions
have wild-type function, as shown from extensive phenotypic testing
(data not shown).
We measured the binding of Spt3 and Spt20 to the GAL1-GAL10
UAS (UASG). The UASG contains four Gal4 binding
sites (Giniger et al. 1985
; Johnston and Carlson 1992
). Our results
show that both Spt3 and Spt20 are bound to the UASG, but only
after the induction of transcription by galactose (Fig.
1). Because Gal4 is bound to UASG
in both noninduced and induced conditions (Giniger et al. 1985
; Selleck
and Majors 1987
; data not shown), the binding of Spt3 and Spt20
correlates with activated transcription.
|
Gcn5 and the SAGA TAFs are also recruited to the UASG
Although the Spt3 and Spt20 components of SAGA are required for
GAL1 transcription, other members of the SAGA complex are largely dispensable for GAL1 transcription, including Gcn5 and the TAFs present in SAGA (hereafter referred to as the SAGA TAFs) (Dudley et al. 1999
; Li et al. 2000
). To examine whether Gcn5 and the
SAGA TAFs are recruited to the UASG as part of SAGA even though they are not required for GAL1 activation, we conducted chromatin immunoprecipitation experiments. First, our results show that
Gcn5 is recruited to the UASG after galactose induction, similar to Spt20 and Spt3 (Fig. 2A).
Second, we assayed for the presence of three of the SAGA TAFs: TAF25,
TAF60, and TAF61/68. Recent studies have demonstrated that the other
TAF-containing complex, TFIID, is not present at the GAL1 TATA
region (Li et al. 2000
); therefore, the only TAF chromatin
immunoprecipitation signal could come from TAFs within SAGA. Our
results show that the three SAGA TAFs are recruited to UASG
(Fig. 2B). In contrast, TAF145, a TFIID-specific TAF not found in SAGA
(Grant et al. 1998a
), is not recruited to GAL1 (Fig. 2B).
Thus, SAGA components not required for GAL1 activation are
recruited along with SAGA components that are required for
GAL1 activation. These results provide the first evidence that
the SAGA complex, as defined by its biochemical purification, exists in
the same form at a promoter in vivo.
|
SAGA recruitment is localized to the UAS
To test if SAGA recruitment is specifically localized to the UASG, we assayed the recruitment of Spt3 and Spt20 over a larger region, spanning from the GAL10 5' region, across UASG and the GAL1 open reading frame, to the GAL1 3' noncoding region. Our results show that Spt3 and Spt20 binding is indeed localized to the UASG (Fig. 3). Thus, the galactose-dependent recruitment of Spt3 and Spt20 to the UASG strongly suggests that SAGA is recruited to the UASG to facilitate TBP binding and transcription initiation in vivo.
|
SAGA is recruited to the UAS regions of several GAL genes of S. cerevisiae
Next, we investigated whether the recruitment of SAGA is specific
for the GAL1-GAL10 region, or whether the complex is also recruited to other galactose-inducible promoters of S. cerevisiae. To do this, we performed chromatin immunoprecipitation
experiments to measure recruitment of Spt20 to the UAS regions of the
GAL2, GAL3, and GAL7 promoters. Whereas
GAL7 is physically adjacent to GAL1 and
GAL10 on chromosome II, the GAL2 and GAL3
genes are located on chromosomes XII and IV, respectively. In these
experiments, we infer that chromatin immunoprecipitation of Spt20
indicates the recruitment of SAGA from our results that all SAGA
components tested are corecruited to the UASG. Our results
demonstrate that Spt20 is recruited to the UAS regions of all of these
genes on induction by galactose (Fig. 4).
The GAL3 gene encodes the Gal3 inducer and is transcribed at a
higher basal level than the GAL1, GAL7, and
GAL10 genes, which encode proteins involved directly in galactose
catabolism (Bajwa et al. 1988
; Johnston and Carlson 1992
). SAGA is not
recruited to the GAL3 UAS under noninducing conditions (Fig.
4), suggesting that the coactivator complex is required for activated
but not basal transcription of the GAL genes.
|
SAGA can be recruited by either the Gal4 or VP16 activation domain
Our analysis has shown that SAGA recruitment to the
GAL1-GAL10 locus is localized to the UASG. In
addition, previous in vitro studies suggest that SAGA is recruited to
promoters by interacting with transcriptional activators (Drysdale et
al. 1998
; Utley et al. 1998
; Massari et al. 1999
; Wallberg et al. 1999
;
Vignali et al. 2000
). We tested if SAGA recruitment in vivo requires
the Gal4 activation domain by using a strain that expresses only the Gal4 DNA-binding domain instead of wild-type Gal4. We found that there
is no detectable recruitment of SAGA in this mutant, even though the
mutant form of Gal4 is bound to the UASG (Fig.
5A and data not shown). Therefore, the Gal4
activation domain is required for recruitment of SAGA.
|
To extend our analysis to another well-characterized activation domain,
we tested the role of SAGA with respect to the transcriptional activator VP16 by using Gal4-VP16 hybrid proteins. These proteins contain the DNA-binding domain of Gal4 and the transcriptional activation domain of VP16. In these experiments, we compared three different activators for their dependence on SAGA and for their ability
to recruit SAGA: wild-type Gal4, Gal4-VP16, and Gal4-VP16-F442A. The
VP16-F442A mutant is approximately twofold less active than wild-type
VP16 (Cress and Triezenberg 1991
; Wang et al. 1995
). In strains with
functional SAGA, but lacking Gal4, both Gal4-VP16 fusions support
strong growth on galactose (Fig. 5B). In an spt20
mutant,
which lacks SAGA, the strains with either form of Gal4-VP16 are
Gal
, indicating a failure to activate GAL gene
transcription (Fig. 5B). In these spt20
mutants, although
there is a reduced level of Gal4-VP16 protein, there is still a
significant level of Gal4-VP16 binding to the UASG, as
measured by chromatin immunoprecipitation (data not shown). The
observed Gal
phenotype is consistent with previous studies
of Gal4-VP16 activation in SAGA mutants (Berger et al. 1992
; Pina et
al. 1993
; Marcus et al. 1994
). Therefore, like the Gal4 activation
domain, the VP16 activation domain requires SAGA function in vivo.
To strengthen the correlation between the requirement of an activation domain for SAGA and its recruitment in vivo, we investigated whether Gal4-VP16 and Gal4-VP16-F442A recruit SAGA. Our results show that, as for Gal4, both Gal4-VP16 and Gal4-VP16-F442A recruit SAGA to the UASG (Fig. 5C). In contrast to Gal4, the Gal4-VP16 hybrids are not subject to regulation by the negative regulator Gal80. Consequently, VP16 recruits SAGA when strains are grown in either raffinose or galactose (Fig. 5C). We also observed that the weaker Gal4-VP16-F442A activator recruits SAGA approximately threefold less well than the stronger wild-type Gal4-VP16 activator. In conclusion, multiple activation domains can recruit SAGA to the UASG and the strength of transcriptional activation correlates with the amount of SAGA recruited.
An Spt3-TBP functional interaction is required for TBP binding but not for SAGA recruitment
Previous studies demonstrated that both SAGA components Spt3 and
Spt20 are important for TBP recruitment to the GAL1 TATA (Dudley et al. 1999
). These studies suggested that Spt3 plays a
specific role within SAGA to facilitate the recruitment of TBP (Eisenmann et al. 1992
; Dudley et al. 1999
). In contrast, there is
substantial evidence that Spt20 plays a broader role in SAGA function
than does Spt3. Biochemical studies have shown that Spt20 is required
for SAGA integrity, whereas Spt3 is not (Grant et al. 1997
; Sterner et
al. 1999
). Furthermore, the level of Spt3 protein is greatly reduced in
an spt20
mutant (data not shown). These results indicate
that the defect in TBP recruitment observed in an spt20
mutant may be caused, at least in part, by the loss of Spt3 function.
To test some of these ideas experimentally, we investigated more
thoroughly the mechanism by which Spt3 facilitates GAL1
activation. First, we examined whether Spt3 is required to recruit SAGA
to the UASG by assaying Spt20 recruitment in an
spt3
mutant. Our results demonstrate that the loss of Spt3
does not significantly impair SAGA recruitment (Fig.
6). Thus, the defect in TBP recruitment
observed in an spt3
mutant occurs at a step after SAGA
recruitment.
|
To test further the hypothesis that Spt3 has a direct role in TBP
recruitment in vivo, we examined a TBP mutant that was suspected to be
defective in its interactions with Spt3 in vivo (Eisenmann et al.
1992
). The spt15-21 mutant, which encodes TBP-G174E, shares many phenotypes with spt3
mutants. Furthermore,
spt15-21 is suppressed by particular spt3 mutations
in an allele-specific fashion, suggesting a direct interaction between
Spt3 and TBP (Eisenmann et al. 1992
). First, we examined the binding of
TBP-G174E to the GAL1 TATA in a strain with wild-type Spt3.
TBP-G174E binds to the GAL1 TATA box at only 8% of the level
observed for wild-type TBP (Fig. 7A). The
reduced level of binding by TBP-G174E is not due to reduced levels of
the mutant TBP protein (data not shown). Then, we measured the binding
of TBP-G174E in an spt15-21 spt3-401 double mutant. The
spt3-401 mutation, encoding Spt3-E240K, is a strong
suppressor of spt15-21 mutant phenotypes (Eisenmann et al.
1992
). In this double mutant, TBP-G174E binding is close to the level
of wild-type TBP (Fig. 7A). Therefore, the TBP-G174E binding defect is
suppressed by the altered form of Spt3, Spt3-E240K. These changes in
TBP binding correlate well with the level of GAL1 mRNA (Fig.
7B). Thus, a mutant Spt3 protein is able to compensate for the
DNA-binding defect of a particular TBP mutant at GAL1,
strongly suggesting a direct role for Spt3 in TBP binding at this
promoter.
|
If Spt3 is important for transcriptional activation by facilitating
recruitment of TBP, then we would expect that TBP does not play a role
in the recruitment of Spt3. We were able to address this issue by
taking advantage of the binding defect of TBP-G174E. We performed
chromatin immunoprecipitation of Spt3, comparing wild-type and
spt15-21 strains. Our results showed that Spt3 recruitment is
unaffected by the spt15-21 mutant, despite the significant reduction in TBP binding (Fig. 7C). Furthermore, as described earlier,
Spt20 recruitment is not significantly affected in an spt3
mutant, although TBP binding is severely reduced (Fig. 6) (Dudley et
al. 1999
). These results strongly suggest that TBP does not play a
significant role in the recruitment of SAGA to UASG.
| |
Discussion |
|---|
|
|
|---|
Coactivators were originally proposed to serve as proteins that act
as bridging molecules between a gene-specific activator and a general
transcription factor such as TBP (for review, see Gill and Tjian 1992
).
The experiments presented in this paper were designed to test the
hypothesis that the SAGA complex plays such a coactivator role in vivo
at the GAL1 promoter. This model makes three key predictions.
First, the SAGA complex should be physically present at the promoters
it regulates. Second, recruitment of the complex should be governed by
an activation signal or activation domain. Finally, the complex should
interact physically and/or functionally with both gene-specific
activators and TBP.
Our results have shown that SAGA fulfills the predicted role of a
coactivator complex in each of these ways. First, SAGA is physically
recruited to the GAL UAS regions. Second, this recruitment is
dependent on induction by galactose and requires an activation domain.
We have shown that either the Gal4 or VP16 activation domain can
recruit SAGA. Third, Spt3 of SAGA is likely devoted to the subsequent
recruitment of TBP to the TATA. This conclusion is based on three
findings: (1) our previous analysis that demonstrated that Spt3 is
required for TBP binding at GAL1 (Dudley et al. 1999
); (2) our
new result concerning the genetic interactions between Spt3 and TBP;
and (3) our new result that Spt3 is not required for SAGA recruitment.
In addition to these results, our work has shown that all six SAGA
components tested are recruited to the UASG on induction by
galactose, although there is evidence that some of these components are
not significantly required for GAL transcription. Finally, our
results strongly indicate that TBP itself is not required for SAGA recruitment.
Taken together with previous studies of transcriptional regulation of
the GAL genes (Johnston and Carlson 1992
; Lohr et al. 1995
)
and our analysis of TBP binding in vivo at GAL1 (Dudley et al.
1999
), these new results strongly suggest a series of dependent steps
within which SAGA functions in the activation of the GAL genes
(Fig. 8). This model is discussed here in
terms of the UASG region between the GAL1 and
GAL10 genes, the UAS studied in most detail in this work. In
this model, in noninducing conditions when the GAL genes are
not expressed, the Gal4 activation domain is blocked by the presence of
Gal80, and SAGA is not present at UASG (Fig. 8, step 1). Then,
on the induction of transcription by galactose, the Gal3 protein causes
an altered Gal80-Gal4 interaction, revealing the Gal4 activation
domain. This causes the physical recruitment of SAGA to the
UASG (Fig. 8, step 2). Finally, SAGA recruits TBP to allow
transcriptional initiation (Fig. 8, step 3). This model is also
strongly supported by the results in Bhaumik and Green (2001
, this
issue).
|
Several important aspects of SAGA recruitment remain to be determined.
First, SAGA will likely have distinct mechanisms for recruitment at
different promoters. For example, analysis of SAGA recruitment to the
HO promoter suggests that its recruitment is dependent on the
Swi/Snf complex and is only indirectly dependent on the HO
activator Swi5 (Cosma et al. 1999
; Krebs et al. 1999
). Thus, the
mechanism of SAGA recruitment to the HO promoter appears to be
distinct from that regulating its recruitment to the GAL promoters. Similar to our results for Gal4, the activator Gcn4 has been
shown to target Gcn5 HAT activity to promoters (Kuo et al. 2000
).
Second, the specific SAGA subunits required for recruitment remain to
be determined at any promoter. Results in this paper have shown that
Spt3 is not required for SAGA recruitment. Earlier in vitro studies
have suggested an interaction between the VP16 activation domain and
the SAGA components Ada2 (Silverman et al. 1994
; Barlev et al. 1995
)
and Spt20 (Marcus et al. 1996
). Possibly, different SAGA subunits
interact with different activation domains or factors for recruitment
to the broad spectrum of genes at which SAGA acts. Very recent results
demonstrate that, in vitro, several activators interact directly with
the SAGA subunit Tra1 (Brown et al. 2001
). Third, SAGA recruitment in
vivo may require additional interactions besides those with an
activation domain. For example, SAGA may also interact directly with
nucleosomes or other transcription factors. However, our results
strongly indicate that an interaction with TBP is not required for SAGA
recruitment. Additional biochemical and genetic studies will be
required to determine the SAGA components and other interactions
necessary for SAGA recruitment.
Our analysis of TBP and Spt3 mutants has also provided strong support
for a direct role of Spt3 in the recruitment of TBP to the
GAL1 TATA region. Previous studies showed a physical
interaction between Spt3 and TBP (Eisenmann et al. 1992
; Lee and Young
1998
) and a significant reduction in the level of TBP bound to the
GAL1 TATA in an spt3 mutant (Dudley et al. 1999
). Our
new experiments have addressed the TBP mutant, TBP-G174E. From mutant
phenotypes, this TBP mutant mimics the loss of Spt3 (Eisenmann et al.
1992
). We have now shown that in an otherwise wild-type background, the binding of TBP-G174E is greatly reduced at the GAL1 TATA.
Significantly, this binding defect is suppressed by the Spt3-E240K
mutant, strongly suggesting that the binding defect of TBP-G174E is
caused by an impaired interaction with Spt3. This conclusion is
consistent with earlier studies that showed that purified TBP-G174E
and purified wild-type TBP bind equally well to the adenovirus major
late promoter TATA sequence in vitro, showing that TBP-G174E has no
inherent defect in DNA binding (Eisenmann et al. 1992
). These results
very strongly suggest that Spt3 directly interacts with TBP in vivo, although we cannot rule out the unlikely possibility that Spt3 acts
indirectly on TBP recruitment. More experiments are required to
determine why particular TATA regions require Spt3 for stable TBP
binding in vivo and the mechanism by which this stabilization occurs.
Our understanding of the TBP-Spt3 interaction has been enhanced by
studies of human homologs. Studies have shown that two human TAFII
proteins, hTAFII18 and hTAFII28, are homologous to the amino-terminal and carboxy-terminal regions of Spt3, respectively (Mengus et al. 1995
; Birck et al. 1998
). An amino acid change in human
TBP, G272E, that is equivalent to the G174E change of S. cerevisiae TBP, impairs the physical interaction between
hTAFII28 and the mutant TBP (Lavigne et al. 1999
).
Furthermore, amino acid changes in the
2 helix region of
hTAFII28, the same conserved region as the Spt3-E240K change
(May et al. 1996
; Birck et al. 1998
), also impair
hTAFII28-hTBP interactions (Lavigne et al. 1999
). Given this
conservation, it seems probable that the roles of hTAFII28
and human Spt3 include the recruitment of TBP to TATA boxes within
specific promoters.
What are the relative roles of Spt3 and SAGA in GAL gene
activation with respect to the other factors that have been identified as important in this regulation? The Gal4 activation domain has previously been shown to interact with TBP, TFIIB, and Srb4 (Melcher and Johnston 1995
; Wu et al. 1996
; Ansari et al. 1998
; Koh et al.
1998
). In addition, Gal4 becomes phosphorylated upon induction and this
phosphorylation is important for Gal4 activation (Rohde et al. 2000
).
Therefore, it seems clear that SAGA is not the only factor important in
activation, and multiple interactions are probably required for the
normal establishment and maintenance of the activated state.
Conceivably, these multiple interactions might occur simultaneously,
each one contributing to the activated state. More likely, they occur
in an ordered fashion. The results of Bhaumik and Green (2001)
strongly
suggest that SAGA plays a critical early role early during
GAL1 activation. For example, SAGA/Spt3 may play a role during
induction, helping to establish a subsequent interaction between Gal4
and TBP that maintains the activated state. Furthermore, other SAGA
components in addition to Spt3 likely contribute toward activation at
GAL1 and may conceivably contribute to TBP recruitment,
because the Gal
phenotype of spt3
mutants is
not as tight as the Gal
phenotype of spt20
mutants, in which SAGA function is completely lost (Horiuchi et al.
1997
; Roberts and Winston 1997
; Sterner et al. 1999
).
Finally, in addition to transcriptional activation, there is strong
evidence that SAGA confers transcriptional repression at certain
promoters (Brandl et al. 1993
, 1996
; Belotserkovskaya et al. 2000
; Lee
et al. 2000
). At the HIS3 promoter, repression appears to be
caused by the inhibition of TBP-DNA binding by Spt3 and Spt8
(Belotserkovskaya et al. 2000
). Future genetic and biochemical analysis
will be required to understand how an Spt3-TBP interaction can be
modulated to confer either transcriptional activation or repression.
| |
Materials and methods |
|---|
|
|
|---|
S. cerevisiae strains, plasmids, and media
All S. cerevisiae strains (Table 1) are isogenic to a
GAL2+ derivative of S288C (Winston et al. 1995
).
Sequences encoding three copies of the HA epitope-tag (designated as
HA3) were integrated at the 5' end of the SPT3 and
SPT20 genes and at the 3' end of the GCN5 gene by
using a PCR-based method described previously (Schneider et al. 1996
).
The GCN5-HA3 construct was made by Jenny Wu (J. Wu and F. Winston, unpubl.). S. cerevisiae strain FY1982 (gal4
::KANMX) was constructed by PCR-mediated gene
disruption in strain FY1976, replacing the entire GAL4 open
reading frame with the kanMX4 cassette, which confers
resistance to G418 (Brachmann et al. 1998
). The plasmids used to test
different activation domains all contained CEN sequences for
low-copy number and LEU2 as the selectable marker in S. cerevisiae. Plasmids A/C GV and A/C FA, containing the chimeric
activators Gal4-VP16 and Gal4-VP16-F442A, respectively, were
provided by Shelley Berger (Berger et al. 1992
). The plasmid pPC97
encoding the Gal4 DNA-binding domain was provided by Steve Buratowski
(Chevray and Nathans 1992
). The plasmid pRS415 was used as a negative
control (Christianson et al. 1992
). For chromatin immunoprecipitation
and Northern analyses, all strains were grown in YPRaf or SC-Leu Raf
(2% raffinose) to cell densities of 1-2 × 107 cells/mL
(Dudley et al. 1999
). Each 400-mL culture was then divided into two
equal volumes and half was induced for 20 min in 2% galactose whereas
the other half remained uninduced. The noninduced samples are referred
to as the "Raf" culture and the induced as the "Gal" culture.
All media were made as described previously (Rose et al. 1990
).
|
Chromatin immunoprecipitation
All chromatin immunoprecipitation was conducted as previously
described (Dudley et al. 1999
; Kuras et al 1999
). Chromatin was
sonicated to an average of 350 bp with a size range of 200-900 bp.
Both one-step and two-step immunoprecipitations were performed (Harlow
and Lane 1999
). The two-step immunoprecipitations were approximately
two times as efficient as the one-step immunoprecipitations. The mouse
monoclonal 12CA5 HA antibody was used (Boehringer Mannheim). The TAF25,
TAF60, TAF68, and TAF145 antibodies (Li et al. 2000
) and the TBP
antibodies (Komarnitsky et al. 2000
) were previously described.
Quantitative radioactive PCR was used to determine the percentage of
GAL1 promoter DNA that coimmunoprecipitated with Spt3 or Spt20
as described previously (Dudley et al. 1999
) with the exception that
the PCR products were detected by the incorporation of
[
-32P]dATP in the reaction. Linearity of all PCR
reactions was assayed by multiple template dilutions of input (IN) and
immunoprecipitated (IP) DNA (IN: 1/25,000 or 1/50,000 of total input
DNA was added to each reaction; IP: 1/50 or 1/100 of total
immunoprecipitated DNA was added to each reaction). Quantitation was
performed by PhosphorImager analysis (Molecular Dynamics). Error for
the quantitation of each PCR reaction was experimentally determined to
be ±10% by conducting multiple repeats of the same PCR reaction.
Furthermore, the specificity of each GAL1 gene PCR product was
assessed by normalizing to a control PCR product amplified within the
same reaction. The control PCR product is a 150-bp region amplified from a region of chromosome V that is outside of any open reading frames (Komarnitsky et al. 2000
). All primer sets spanning the GAL loci yield products that range in size from 240 bp to 350 bp. To visualize binding of Spt3 and Spt20 to the GAL1 gene
under both inducing and noninducing conditions on the same
polyacrylamide gel, we loaded 6% nondenaturing gels consecutively with
the PCR samples first from noninduced and then galactose-induced
chromatin immunoprecipitations. The percent IP (Gal/Raf) values were
calculated as follows: (1) the percent of input DNA immunoprecipitated
(% IP) was calculated for both Gal and Raf immunoprecipitations by quantitating PCR products resulting from multiple dilutions of input
and immunoprecipitated template DNA; (2) the Gal % IP and Raf % IP
values were normalized to the internal control PCR product by dividing
each by the respective control % IP; and (3) the ratio of the
normalized Gal % IP to the normalized Raf % IP was calculated, and
this value is reported as % IP (Gal/Raf). The primers used for the
control PCR (Komarnitsky et al. 2000
) and for the GAL1-GAL10 region (Dudley et al. 1999
; Santisteban et al. 2000
) were described previously. All other primers were created for this study and primer
sequences are available on request.
Northern hybridization analysis
Total yeast RNA was prepared as described previously (Swanson et
al. 1991
). Northern blot analysis was performed on each of four
independent experiments and the average quantitation of the results is
shown (Fig. 7B). The GAL1 (St John and Davis 1981
) and
TPI1 (Hirschhorn et al. 1992
) probes have been described previously.
| |
Acknowledgments |
|---|
We thank Sukesh Bhaumik, Michael Green, and Steve Buratowski for providing antibodies, Steve Buratowski and Mitchell Smith for providing primer sequences, Jenny Wu for providing the GCN5-HA3 construct, and Steve Buratowski and Shelley Berger for providing plasmids. We also thank Sukesh Bhaumik and Michael Green for sharing unpublished results. We are grateful to Aimée Dudley, Mary Bryk, and Richard Larschan for helpful comments on the manuscript. This work was supported by NIH grant GM45720.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received May 15, 2001; revised version accepted June 14, 2001.
1 Corresponding author.
E-MAIL Winston{at}rascal.med.Harvard.edu; FAX (617) 432-3993.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.911501.
| |
References |
|---|
|
|
|---|